Haynes and Boone's Newsroom

Life Sciences Patent Attorney Paul Dietze Arrives at Haynes and Boone Washington, D.C. Office
05/23/2011


WASHINGTON
Paul Dietze, Ph.D., an intellectual property attorney whose practice centers on patent prosecution and opinion drafting in the life sciences sector, has moved to an of counsel position in the Washington, D.C. office of Haynes and Boone, LLP.

Dr. Dietze adds depth to the firm’s generic pharmaceutical IP practice with an unusually strong technical background. He holds a doctorate in organic chemistry, taught chemistry for several years at the collegiate level and worked as a review chemist for five years at the U.S. Food and Drug Administration.

“Paul’s training makes him truly unique in our litigation and transactional IP practice,” said Partner Randall Brown, head of the Haynes and Boone Intellectual Property and Technology Transactions Section. “With six years of experience representing generic pharmaceutical firms, he is sure to provide expanded service to our clients in need of Hatch-Waxman assistance. We are very excited Paul has decided to join our growing D.C.-based IP group.”

He arrives at Haynes and Boone with a total of thirteen years experience in all aspects of client counseling and patent prosecution in the pharmaceutical and chemical arts industry, including preparing non-infringement and/or invalidity opinions, portfolio analysis, and development and implementation of strategic patent programs.
Paul’s experience in patent prosecution involves both domestic and foreign prosecution including drafting applications, responding to office actions, interviewing examiners, inventorship determinations, preparing patent term extensions, reissue proceedings, re-examination proceedings, preparing appeal briefs and arguing appeals at the Board of Patent Appeals and Interferences.

Dr. Dietze received his law degree from the University of Maryland School of Law in 1998 and served as a postdoctoral research fellow at the Brandeis University biochemistry department after obtaining his Ph.D. in organic chemistry from the New York University Graduate School of Arts and Sciences.